PARP1 and head and neck cancer: Finally, because inhibition of poly(ADP-ribose) polymerase (PARP), a key DNA repair enzyme, could improve the efficacy of radiotherapy in human head and neck cancer [21], we determined the combined effects of the Syk and PARP inhibitors on cell viability in SCC.